ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Enhancing Immunotherapy of Neuroblastoma||The Regents of the University of California, San Diego / Alice Yu, MD/PhD & Mitchell Diccianni, PhD||Innovation Grants||2016||California|
|Detection of Circulating Tumor DNA in Pediatric Sarcomas||The Regents of the University of California San Francisco / Alejandro Sweet-Cordero, MD & Maximillian Diehn, MD/PhD (Stanford University)||Innovation Grants||2016||California|
|Targeted Combination Therapy to Sensitize High-Risk Acute Lymphoblastic Leukemia to Methotrexate via Restoration of Ikaros Tumor Suppression||The Pennsylvania State University / Sinisa Dovat, MD/PhD & Chunhua Song, MD/PhD||Innovation Grants||2016||Pennsylvania|
|Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma||The Johns Hopkins University School of Medicine / Eric Raabe, MD/PhD & Dr. Barbara Slusher, PhD||Innovation Grants||2016||Maryland|
|Modeling Pediatric Spinal Gliomas Using Murine Spinal Neural Stem Cells||The Johns Hopkins University School of Medicine / Charles Eberhart, MD/PhD & Eric Raabe MD/PhD||Innovation Grants||2016||Maryland|
|Targeting the Function of Ezrin in Rhabdomyosarcoma||The Cleveland Clinic Foundation / Neetu Gupta, PhD & Peter Anderson, MD||Innovation Grants||2016||Ohio|
|DFMO Synergy with Chemo-immunotherapy to Eradicate MYC-Driven Neuroblastoma||Children's Hospital of Philadelphia / Michael Hogarty, MD||Reach Grants||2016||Pennsylvania|
|Astatine-211 Meta-Astatobenzylguanidine ([211At]MABG) Targeted Radiotherapy for Disseminated Neuroblastoma||Children's Hospital of Philadelphia / John Maris, MD||Reach Grants||2016||Pennsylvania|
|CD19 Delta Ex2 Isoform as a Target for Alternative Therapies in Relapsed Pediatric B-ALL||Children's Hospital of Philadelphia / Asen Bagashev, PhD||Young Investigator Grants||2016||Pennsylvania|
|GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma||Children's Hospital of Philadelphia / Kristopher Bosse, MD||Young Investigator Grants||2016||Pennsylvania|